<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=4423596&amp;fmt=gif">
Discover AGCellerate for LVV - a faster option to get your GMP-ready lentiviral vector product   Learn about AGCellerate

AGC Biologics in the news for our work toward COVID-19 treatment

Seattle CBS affiliate KIRO visited our Bothell, Washington headquarters to interview AGC Biologics CEO Patricio Massera and Chief Business Officer Mark Womack about the work we’re doing with partner CytoDyn. CytoDyn scientists discovered that HIV drug leronlimab could potentially work to treat COVID-19. AGC Biologics is producing a key molecule for the drug.

HubSpot Video